The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.

The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease.

Previous work has shown an association between the K variant of the butyrylcholinesterase (BCHE) gene and Alzheimer's disease (AD) in patients carrying the epsilon4 allele of ApoE. We attempted to replicate this finding in 181 UK white AD cases and 71 controls. No difference was found in BCHE-K...

Полное описание

Библиографические подробности
Главные авторы:	Kehoe, P, Williams, H, Holmans, P, Wilcock, G, Cairns, N, Neal, J, Owen, M
Формат:	Journal article
Язык:	English
Опубликовано:	1998

Схожие документы

Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease.
по: Kehoe, P, и др.
Опубликовано: (1999)

Association between a PS-1 intronic polymorphism and late onset Alzheimer's disease.
по: Kehoe, P, и др.
Опубликовано: (1996)

Onset of Alzheimer disease in apolipoprotein ɛ4 carriers is earlier in butyrylcholinesterase K variant carriers
по: Roger M. Lane, и др.
Опубликовано: (2024-04-01)

Presenilin-1 polymorphism and Alzheimer's disease. The UK Alzheimer's Disease Collaborative Group.
по: Kehoe, P, и др.
Опубликовано: (1996)

Association of butyrylcholinesterase K variant with cholinesterase-positive neuritic plaques in the temporal cortex in late-onset Alzheimer's disease.
по: Lehmann, D, и др.
Опубликовано: (2000)

Presenilin-1 polymorphism and Alzheimer's disease [6]
по: Kehoe, P, и др.
Опубликовано: (1996)

Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation.
по: Holmes, C, и др.
Опубликовано: (2005)

Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease.
по: Kehoe, P, и др.
Опубликовано: (2004)

ApoE epsilon 2 and butyrylcholinesterase K variant are associated with coronary heart disease in type 2 diabetes
по: Horton, V, и др.
Опубликовано: (2000)

Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain.
по: Blomqvist, M, и др.
Опубликовано: (2005)

Butyrylcholinesterase K variant is associated with type 2 diabetes in UK Caucasians
по: Hashim, Y, и др.
Опубликовано: (2000)

Association between butyrylcholinesterase K variant and mild cognitive impairment in the Thai community-dwelling patients
по: Pongthanaracht N, и др.
Опубликовано: (2017-05-01)

Flavonoids as Inhibitors of Human Butyrylcholinesterase Variants
по: Maja Katalinić, и др.
Опубликовано: (2014-01-01)

Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
по: Kehoe, P, и др.
Опубликовано: (2007)

Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients.
по: Tasker, A, и др.
Опубликовано: (2008)

Common variants of ACE contribute to variable age at onset of Alzheimer's disease
по: Katzov, H, и др.
Опубликовано: (2004)

Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism.
по: Katzov, H, и др.
Опубликовано: (2004)

The renin angiotensin system in Alzheimer's disease - Do updates high-light a clinical and biological dichotomy?
по: Kehoe, P, и др.
Опубликовано: (2006)

Obesity and variants of the GHRL (ghrelin) and BCHE (butyrylcholinesterase) genes
по: Vitor G.L. Dantas, и др.
Опубликовано: (2011-01-01)

Kinetics and computational study of butyrylcholinesterase inhibition by methylrosmarinate: relevance to Alzheimer’s disease treatment
по: Sani Muhammad Uzairu, и др.
Опубликовано: (2022-09-01)

Butyrylcholinesterase K variant on chromosome 3 q is associated with Type II diabetes in white Caucasian subjects.
по: Hashim, Y, и др.
Опубликовано: (2001)

Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease.
по: Culpan, D, и др.
Опубликовано: (2003)

Benzene-1,3-diol derivatives as the inhibitors of butyrylcholinesterase: An emergent target of Alzheimer’s disease
по: Dongliang Yin, и др.
Опубликовано: (2022-01-01)

Aaptamine – a dual acetyl – and butyrylcholinesterase inhibitor as potential anti-Alzheimer’s disease agent
по: Shuang Miao, и др.
Опубликовано: (2022-12-01)

Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer’s Disease—Could <i>BCHE</i> Genotyping Be Helpful in Alzheimer’s Therapy?
по: Jacek Jasiecki, и др.
Опубликовано: (2019-10-01)

TNFR-associated factor-2 (TRAF-2) expression in Alzheimer's disease
по: Culpan, D, и др.
Опубликовано: (2004)

The relationship between CAV-1 and cerebral amyloid angiopathy in Alzheimer's disease
по: Chalmers, K, и др.
Опубликовано: (2004)

Widely Spread Butyrylcholinesterase Can Hydrolyze Acetylcholine in the Normal and Alzheimer Brain
по: Marsel Mesulam, и др.
Опубликовано: (2002-02-01)

Haplotypes extending across ACE are associated with Alzheimer's disease.
по: Kehoe, P, и др.
Опубликовано: (2003)

Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer’s disease
по: Chuanyu Yu, и др.
Опубликовано: (2024-12-01)

Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease
по: Ana Matošević, и др.
Опубликовано: (2022-09-01)

Investigation of Association between Susceptibility to Leprosy and SNPs inside and near the BCHE Gene of Butyrylcholinesterase
по: Henrique J. P. Gomes, и др.
Опубликовано: (2012-01-01)

The ACE gene and Alzheimer's disease susceptibility.
по: Narain, Y, и др.
Опубликовано: (2000)

Biophenols of mints: Antioxidant, acetylcholinesterase, butyrylcholinesterase and histone deacetylase inhibition activities targeting Alzheimer’s disease treatment
по: Doaa M. Hanafy, и др.
Опубликовано: (2017-06-01)

Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors Based on the Pyridyl–Pyridazine Moiety for the Potential Treatment of Alzheimer’s Disease
по: Mohamed Elsawalhy, и др.
Опубликовано: (2024-10-01)

Correction: Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka.
по: Leo Pezzementi, и др.
Опубликовано: (2011-01-01)

Treating Alzheimer's disease.
по: Wilcock, G, и др.
Опубликовано: (1995)

Evolution of acetylcholinesterase and butyrylcholinesterase in the vertebrates: an atypical butyrylcholinesterase from the Medaka Oryzias latipes.
по: Leo Pezzementi, и др.
Опубликовано: (2011-02-01)

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.
по: Miners, J, и др.
Опубликовано: (2006)

Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease.
по: Culpan, D, и др.
Опубликовано: (2007)